ICECAPNCT06939374
Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With Stable Angina or ACS - A Traditional Feasibility Study
At risk: Primary completion moved 11 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Jan 31, 2027 to Dec 31, 2027 Show 5 more changesShow less
- Start date: Mar 1, 2025 to Mar 1, 2026
- Study completion pushed from Jun 30, 2027 to Apr 30, 2028
- Eligibility criteria expanded, about 12 words
- Secondary endpoints: details revised at 4 of 15 entries
- Site details revised at 1 of 3 sites
Notable Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
- Primary endpoints: 1 to 2
- Enrollment target: 25 to 30
- Study sites: 0 to 3
- Start date changed from estimate of Jun 1, 2025 to Mar 1, 2025
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Primary efficacy endpoint
Timeframe: At 9 months post-CTS procedure compared to baseline.
co-primary safety endpoint
Timeframe: at 30 days post procedure
Secondary (15)
Change in Fibrous Cap Thickness
Change in Minimal Lumen Area (MLA)
Prevalence of Thin Cap Fibrous Atheroma
Prevalence of lipid Arc >90°
Prevalence of lipid Arc >180°
Show 10 moreShow less
Prevalence of lipid Arc >270°
Total angle of macrophage
Maximum angle of macrophage
Total angle of lipidic plaque
Maximum angle of lipidic plaque
Total angle of calcification
Maximum angle of calcification
Total Plaque volume
Calcified Plaque volume
Area stenosis
Arms and interventions
Treatment armExperimental
Subjects with coronary HRP lesions treated with intracoronary cryotherapy using the CTS device
Devices: Intracoronary Cryotherapy
Sites
3 sites in 2 countries
United Kingdom 2, Belgium 1